KLF2 could impede angiogenesis by inhibiting the promoter activity of VEGFR2 [32], whereas the downregulation of KLF2 by exosomal miR-25-3p could promote vascular permeability and angiogenesis in CRC [15]. The gene discussed is KDR; the disease is colorectal carcinoma.